<DOC>
	<DOCNO>NCT00510146</DOCNO>
	<brief_summary>The purpose study ass whether olanzapine superior placebo patient bipolar depression .</brief_summary>
	<brief_title>Olanzapine Treatment Patients With Bipolar I Disorder</brief_title>
	<detailed_description>1 . Dose range administration mode : Oral Olanzapine 5mg - 20mg/day 2 . Duration : 1 . Screening phase 2-28 day . 2 . Double-blind treatment phase 6 week 3 . Open-label extension phase 18 week</detailed_description>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Each patient must reliable , level understanding sufficient perform test examination require protocol , must understand nature study provide informed consent All female patient must test negative pregnancy female breastfeed potential must agree breastfeed infant study 1 month follow last dose study drug Patients must fulfill criterion major depressive episode accord Diagnostic Statistical Manual Mental Disorders , Fourth Edition ( DSMIVTR ) well criterion bipolar I disorder , depress , define DSMIVTR , base clinical assessment confirm structured diagnostic interview , Mini International Neuropsychiatric Interview ( MINI ) , study entry Patients must current 17item Hamilton Depression Rating Scale ( HAMD17 ) score great equal 18 Visit 1 Visit 2 Patients must current Young Mania Rating Scale ( YMRS ) total score less equal 8 Visit 2 . Has receive treatment within past 30 day drug ( include study drug ) receive regulatory approval indication time study entry Has participate clinical trial another investigational drug , include olanzapine , within 1 month ( 30 day ) study entry Was previously treat olanzapine bipolar depression consider treatmentresistant olanzapine olanzapine combination available selective serotonin reuptake inhibitor ( SSRI ) Is experience ( time study entry ) current episode bipolar depression great 90 day duration Has treatmentresistant therapy prescribe bipolar depression olanzapine alone SSRI prescribe appropriate dose duration</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>